Promising leukemia combo trial halted early – what we know
NCT ID NCT04240002
First seen Jan 09, 2026 · Last updated May 06, 2026 · Updated 17 times
Summary
This study tested a drug called gilteritinib, which targets a specific genetic change (FLT3/ITD) in acute myeloid leukemia (AML), combined with standard chemotherapy. It included children, teens, and young adults whose leukemia had come back or didn't respond to treatment. The goal was to find the best dose and see how many patients achieved remission. The study was stopped early after enrolling only 9 participants, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SIte IT39001
Roma, 165, Italy
-
Site DE49004
Essen, North Rhine-Westphalia, 45147, Germany
-
Site ES34001
Barcelona, 08950, Spain
-
Site GB44001
Birmingham, B4 6NH, United Kingdom
-
Site GB44005
Cardiff, CF14 4XW, United Kingdom
-
Site UK44007
Sutton, United Kingdom
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.